fingolimod hydrochloride has been researched along with Astrocytoma, Grade IV in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 5 (45.45) | 2.80 |
| Authors | Studies |
|---|---|
| Doello, K; Mesas, C; Ortiz, R; Perazzoli, G; Quiñonero, F; Rama, AR; Vélez, C | 1 |
| Liu, L; Ma, M; Wu, H; Zhang, Y | 1 |
| Cambron, B; Delrée, P; Gustin, T; Jacobs, S; London, F | 1 |
| Cheng, H; Guo, RB; Guo, XD; Ji, J; Sun, XL; Sun, YQ; Xue, TF | 1 |
| Al Barim, B; Di Fazio, P; Kolodziej, MA; Nagl, J; Schwarm, FP; Stein, M; Uhl, E; Uhle, F; Weigand, MA | 1 |
| Wang, H; Zhang, L | 1 |
| Alessandri, G; Bornati, A; Campanella, R; de Rezende, G; Di Vito, C; Giussani, P; Hadi, LA; Marfia, G; Navone, SE; Parati, E; Rampini, P; Riboni, L; Riccitelli, E; Tringali, C; Viani, P | 1 |
| Ding, K; Wang, H; Xu, J; Zhang, L; Zhu, J | 1 |
| Ding, K; Wang, H; Xu, J; Zhang, L | 1 |
| Golzy, N; Pouratian, N; Sharim, J; Tashjian, R | 1 |
| Estrada-Bernal, A; Palanichamy, K; Ray Chaudhury, A; Van Brocklyn, JR | 1 |
11 other study(ies) available for fingolimod hydrochloride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines.
Topics: Adult; Apoptosis; Biperiden; Brain Neoplasms; Cell Line, Tumor; Dextromethorphan; Fingolimod Hydrochloride; Glioblastoma; Haloperidol; Humans; Levetiracetam; Methotrimeprazine; Valproic Acid | 2022 |
Modulation of blood-brain tumor barrier for delivery of magnetic hyperthermia to brain cancer.
Topics: Blood-Brain Barrier; Brain Neoplasms; Endothelial Cells; Fingolimod Hydrochloride; Glioblastoma; Humans; Hyperthermia, Induced; Magnetic Phenomena | 2023 |
Glioblastoma in a fingolimod-treated multiple sclerosis patient: Causal or coincidental association?
Topics: Brain; Brain Neoplasms; Female; Fingolimod Hydrochloride; Glioblastoma; Humans; Middle Aged; Multiple Sclerosis; Sphingosine 1 Phosphate Receptor Modulators | 2020 |
FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia.
Topics: Allografts; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Polarity; Disease Models, Animal; Fingolimod Hydrochloride; Glioblastoma; Macrophages; Male; Microglia; Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, CXCR4; Signal Transduction; Tumor Microenvironment | 2020 |
Sphingosine‑1‑phosphate analogue FTY720 exhibits a potent anti‑proliferative effect on glioblastoma cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Fingolimod Hydrochloride; Glioblastoma; Humans; rho-Associated Kinases; Signal Transduction; Sphingosine 1 Phosphate Receptor Modulators; Temozolomide | 2020 |
FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
Topics: Antineoplastic Agents, Alkylating; Antioxidant Response Elements; Apoptosis; Autophagy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Fingolimod Hydrochloride; Gene Knockdown Techniques; Glioblastoma; Heme Oxygenase-1; Humans; NF-E2-Related Factor 2; RNA, Messenger; RNA, Small Interfering; Temozolomide | 2017 |
Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
Topics: Animals; Brain Neoplasms; Cell Proliferation; Cells, Cultured; Ceramides; Epidermal Growth Factor; Extracellular Fluid; Fibroblast Growth Factor 2; Fingolimod Hydrochloride; Glioblastoma; Humans; Immunosuppressive Agents; Ki-67 Antigen; Lysophospholipids; Mice; Mice, SCID; Middle Aged; Neoplastic Stem Cells; Propylene Glycols; Sphingolipids; Sphingosine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway.
Topics: Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Fingolimod Hydrochloride; Glioblastoma; Humans; Immunosuppressive Agents; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Propylene Glycols; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sphingosine; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Wound Healing | 2014 |
FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Biomarkers; Cell Line, Tumor; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Glioblastoma; Humans; Male; Membrane Proteins; Mice, Nude; Necrosis; Neoplasm Proteins; Propylene Glycols; Reactive Oxygen Species; Receptor-Interacting Protein Serine-Threonine Kinases; RNA Interference; Signal Transduction; Sphingosine; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Topics: Brain Neoplasms; Female; Fingolimod Hydrochloride; Glioblastoma; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis, Relapsing-Remitting | 2016 |
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Brain Neoplasms; Dacarbazine; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Glioblastoma; Humans; Induction Chemotherapy; Membrane Proteins; Mice; Mice, Nude; Neoplastic Stem Cells; Propylene Glycols; Proto-Oncogene Proteins; Receptors, Lysosphingolipid; Sphingosine; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |